Review of the treatment of metastatic non small cell lung carcinoma: A practical approach

doi:10.5306/wjco.v2.i6.262

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 2, Issue 6

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2828)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-3) series.

Item

Count

PDF

255

HTML

2246

Figures (1-2)

145

Tables (1-3)

182

Sum=2828

Jun 10, 2011 (publication date) through May 15, 2024

Times Cited of This Article

Times Cited (9)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Clin Oncol. Jun 10, 2011; 2(6): 262-271
Published online Jun 10, 2011. doi: 10.5306/wjco.v2.i6.262

Open in New Tab Full Size Figure Download Figure

Figure 1 First-line bevacizumab data in non small cell lung carcinoma. CP: Carboplatin, paclitaxel; CG: Cisplatin, gemcitabine. ¹Investigator assessment.

Open in New Tab Full Size Figure Download Figure

Figure 2 Comparison of overall survival with the most frequently given regimens in first-line treatment of metastatic non small cell lung carcinoma. ¹Scagliotti et al[7]; ²Pirker et al[20]; ³Sandler et al[14]. HR: Hazard ratio; OS: Overall survival.

Citation: Hirsh V. Review of the treatment of metastatic non small cell lung carcinoma: A practical approach. World J Clin Oncol 2011; 2(6): 262-271
URL: https://www.wjgnet.com/2218-4333/full/v2/i6/262.htm
DOI: https://dx.doi.org/10.5306/wjco.v2.i6.262